Trent Carrier is the chief operating officer at L7 Informatics, where he leads financial, legal, H.R., and business operations in addition to leading product development for therapeutics customers. Dr. Carrier joined L7 from Kiadis Pharma, where he was a senior vice president of Product Development following the acquisition of CytoSen Therapeutics, an immunotherapy company where he was a CEO. Prior to CytoSen, Dr. Carrier held management positions at Takeda Pharmaceuticals and Biologics Consulting Group. Dr. Carrier began his career in vaccine manufacturing at Merck and Co, followed by product management roles at Life Technologies. Dr. Carrier has a PhD in Chemical Engineering from the University of California Berkeley and an MBA from the Darden School at the University of Virginia. Throughout his career, Dr. Carrier has worked across the full range of biologic modalities as well as at all stages of therapeutic development.
You're Invited to Join KGI for our In-Person Visit Day! April 5 | 9 a.m. - 2 p.m. PST. REGISTER TODAY.